320 related articles for article (PubMed ID: 11529695)
1. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
[TBL] [Abstract][Full Text] [Related]
2. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.
Simioni P; Tormene D; Prandoni P; Zerbinati P; Gavasso S; Cefalo P; Girolami A
Blood; 2002 Mar; 99(6):1938-42. PubMed ID: 11877263
[TBL] [Abstract][Full Text] [Related]
3. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
Middeldorp S; Henkens CM; Koopman MM; van Pampus EC; Hamulyák K; van der Meer J; Prins MH; Büller HR
Ann Intern Med; 1998 Jan; 128(1):15-20. PubMed ID: 9424976
[TBL] [Abstract][Full Text] [Related]
4. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
[TBL] [Abstract][Full Text] [Related]
5. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
Spannagl M; Heinemann LA; Schramm W
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
[TBL] [Abstract][Full Text] [Related]
6. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.
Juul K; Tybjaerg-Hansen A; Schnohr P; Nordestgaard BG
Ann Intern Med; 2004 Mar; 140(5):330-7. PubMed ID: 14996674
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
[TBL] [Abstract][Full Text] [Related]
10. Incidence of venous thromboembolism in families with inherited thrombophilia.
Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
[TBL] [Abstract][Full Text] [Related]
11. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
Br J Haematol; 2002 Mar; 116(3):625-31. PubMed ID: 11849222
[TBL] [Abstract][Full Text] [Related]
12. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
Rodeghiero F; Tosetto A
Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.
Franco RF; Middeldorp S; Meinardi JR; van Pampus EC; Reitsma PH
Br J Haematol; 2000 Oct; 111(1):118-21. PubMed ID: 11091190
[TBL] [Abstract][Full Text] [Related]
15. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
18. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study.
Heit JA; Sobell JL; Li H; Sommer SS
J Thromb Haemost; 2005 Feb; 3(2):305-11. PubMed ID: 15670037
[TBL] [Abstract][Full Text] [Related]
19. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
20. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?
Procare Group
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):523-9. PubMed ID: 12960604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
